Programme

Please refer to the conference programme

Registration

Register for the conference

Information

General information about the conference

Welcome to
XIII EOTTD Meeting

On May 23 and 24, 2025, the 13th meeting of the European Organisation for the Treatment of Trophoblastic Disease (EOTTD) will be held at the Hospital Clínico San Carlos, Madrid (Spain).

Dear colleagues:

We are honoured and delighted to welcome you to the XIII European Organisation for the Treatment of Trophoblastic Diseases (EOTTD) meeting in Madrid!

The meeting will take place in the auditorium of Hospital Clinico san Carlos (Madrid, Spain) on Friday 23 and Saturday 24th of May 2025.

The meeting will start at 8.15 am on the 23rd of May 2025 and will be finishing at 5.45 pm, in which the european key opinion leaders in Gestational Trophoblastic Diseases will give invaluable lectures on the topic. A social activity will follow from 5.45 onwards, where there will be plenty of time for networking and enjoyment.

We would like to encourage the residents in training to submit their abstracts in the abstract section of this website. The abstracts will be selected for either poster or oral presentations. We will select the best oral abstract to win a prize! Please, see more information in the abstract section.

On Saturday, the 24th of May 2025, we will host the EOTTD closed meeting for its working parties.

We are looking forward to seeing you in Madrid!

On behalf of the organizing committee,

Dr Gloria Marquina
Dr Antonio Casado

Speakers

Dr. Fabienne Allias

MD Pathologic Anatomy Specialist Pathologic Anatomy Specialist. Hospices Civils de Lyon (Centre Hospitalier Universitaire de Lyon) | CHU Lyon · Service Central d’Anatomie et Cytologie Pathologiques Specialist in Pathological Anatomy. Pathologist expert in Gestational Trophoblastic Disease.

Lotte Boog

Nurse Case manager for Gestational Trophoblastic Disease at the Amsterdam Cancer Institute (NKI), Netherlands.

Dr. Antonio Casado

Specialist in Medical Oncology. Head of the Medical Oncology Section at the Hospital Clínico San Carlos.

Associate Professor, Department of Medicine, Faculty of Medicine, Complutense University of Madrid.

Natashia Cedeno

Macmillan Clinical Nurse Specialist for Gestational Trophoblastic Diseases at the Charing Cross Hospital.

Dr. Leonoor Coopmans

Specialist in Gynecologic Oncology. Amsterdam Cancer Institute (NKI), Netherlands.

Aoife Corcoran

Obstetrics and Gynaecology Specialist Registrar in Cork University Maternity Hospital, Ireland.

Dr. John Coulter

Specialist in Gynecologic Oncology at Cork Hospital (Ireland). Promoter of the national registry of gestational trophoblastic disease in Ireland. President of the multidisciplinary committee of gynecologic oncology in Ireland. Member of the educational committee of the European Organization for the Treatment of Trophoblastic Diseases (EOTTD).

Dr. Susanne Fridsten

Specialist Physician in Nuclear Medicine. Karolinska Institutet (Stockholm, Sweden) International expert in Nuclear Medicine and Trophoblastic Disease chosen for the creation of the new FIGO classification of Gestational Trophoblastic Disease.

Dr. Ehsan Ghorani

Medical Oncologist. Charing Cross Hospital (London, United Kingdom). Active researcher in gestational trophoblastic disease.

Dr. Andrea Gmür

Gynecology and Obstetrics Specialist. Bern Hospital (Switzerland). Member of the educational committee of the European Organisation for the Treatment of Trophoblastic Diseases (EOTTD).

Dr. Ulrika Joneborg

Specialist in Gynecologic Oncology. Department of Women’s and Children’s Health, Karolinska Institutet (Stockholm, Sweden) President of the European Organization for the Treatment of Trophoblastic Diseases (EOTTD) since 2023. Expert in Gestational Trophoblastic Disease.

Dr. Baljeet Kaur

Specialist in Pathology. Charing Cross Hospital (London, United Kingdom). One of the most expert pathologists worldwide on Gestational Trophoblastic Disease.

Dr. Adrian Lim

Specialist in Radiodiagnosis. Charing Cross Hospital (London, United Kingdom) Expert in gynecological ultrasound of gestational trophoblastic disease and neoplasia.

Dr. Christianne Lok

Specialist in Gynecologic Oncology at the Center of Gynaecologic Oncology Amsterdam, The Netherlands. Former President of the European Organization for the Treatment of Trophoblastic Disease (EOTTD). One of the Chairs of the of the international guidelines for Gestational Trophoblastic Disease 2025.

Dr. Geoffrey J Maher

Geneticist Geneticist. Charing Cross Hospital (London, United Kingdom) One of the world’s leading experts in genetics of gestational trophoblastic disease and neoplasia. Active member of the laboratory group within the European Organization for the Treatment of Trophoblastic Diseases (EOTTD).

Dr. Gloria Marquina

Specialist in Medical Oncology at the San Carlos Clinical Hospital. Teaching Collaborating Physician at the Faculty of Medicine of the Complutense University of Madrid.

Jerome Massardier

Gynaecologist at Hospices Civils (Lyon), GTD referral centre in France. GTD expert.

Dr. Lesley McMahon

Biologist. Ninewells Hospital Dundee (Scotland, United Kingdom). Clinical scientist in the Hydatidiform Mole Follow-up Service in Scotland.

Dr. Katie McDonald

Specialist Physician in Pathological Anatomy. Sheffield Hospital (Shefield, United Kingdom) Director of the histopathology department of the Supraregional Service of Gestational Trophoblastic Disease and receives referrals for second opinions in the north of England and Wales.

Dr. Ramiro Méndez

Specialist Physician in Radiodiagnosis Head of the Radiodiagnosis Section – Abdomen. Associate Professor of the Department of Radiology and Physical Medicine at the Faculty of Medicine of the Complutense University of Madrid.

Dr. Nelleke Ottevanger

Specialist in Medical Oncology. Radboud University Nijmegen Medical Centre (Nijmegen, Netherlands) Former President of the European Organisation for Gynaecological Tumours (EORTC). Expert in gestational trophoblastic disease and neoplasia.

Dr. Naveed Sanwar

Specialist in Medical Oncology. Charing Cross Hospital (London, United Kingdom). Active researcher in gestational trophoblastic disease.

Dr. Ricardo Savirón

Specialist Physician in Gynecology and Obstetrics. Head of Obstetric Ultrasound at the Hospital Clínico San Carlos.

Dr. Michael Seckl

Specialist in Medical Oncology. Charing Cross Hospital (London, United Kingdom) Founding member of the European Organization for the Treatment of Trophoblastic Diseases (EOTTD). World’s leading expert on gestational trophoblastic disease, as he works at Charing Cross Hospital (London, United Kingdom), the leading international reference centre for gestational trophoblastic disease.

Kamaljit Singh

Nurse case manager for Gestational Trophoblastic Disease at Sheffield Hospital (Sheffield, UK). Active member of the nursing group of the European Organisation for the Treatment of Trophoblastic Diseases (EOTTD).

Lone Sunde

Genetics specialist in Gestational trophoblastic diseases. Professor, Aalborg University Hospital Aarhus, Central Denmark Region, Denmark.

Fred Sweep

Full professor of Laboratory Medicine and head of the department of Laboratory Medicine at Radboud UMC university medical center. Expert in hCG, EOTTD board member and head of the EOTTD hCG working group.

Dr. Grzegorz Szewczyk

MD Gynecologic Oncologist Head of the Department of Obstetrics, Gynecology and Gynecologic Oncology at the Mazovian Provincial Hospital in Siedlce. Specialist in gynecology and obstetrics and gynecologic oncology. Assistant professor at the Department of Biophysics, Physiology and Pathophysiology at the Medical University of Warsaw. Responsible for updates to the website and e-mail newsletters of the European Organization for the Treatment of Trophoblastic Diseases (EOTTD).

Dr. Nienke van Trommel

Specialist in Gynecologic Oncology. Antoni van Leeuwenhoek (Amsterdam, Netherlands) Secretary of the World Organization for Women with Trophoblastic Diseases (ISSTD). She has been secretary of the European Organization for the Treatment of Trophoblastic Diseases (EOTTD) and president of the Amsterdam Trophoblastic Team (ATT). Current Treasurer of the European Organization for the Treatment of Trophoblastic Diseases (EOTTD).

Manuela Undurraga

Head of the Gynaecological oncology Unit at Geneva’s University Hospital, Switzerland.

Dr. Mathew Winter

Specialist in Medical Oncology Specialist in Gynaecological Oncology. Sheffield Hospital (Sheffield, United Kingdom) Secretary of the European Organisation for the Treatment of Trophoblastic Diseases (EOTTD). Promoter of the international registry on placental trophoblastic tumour and epithelioid trophoblastic tumour.

Important dates

12 February – Registration opens
21 April at 23.59 (CET) – New submission of abstract deadline
29 April  – Confirmation of abstract acceptance
16 May – Registration closes
23 May – Scientific program
24 May – EOTTD working parties

Under the Auspices of:

Avalado por ESGO
Logo GEICO
Logo GETTHI
Logo RANME
Logo SEAP IAP
Logo SEGO
Logo UCM

Accreditation

* Accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 4.0 European CME credits (ECMEC®s)

Logo UE MS EACCME

© Copyright - XIII EOTTD Meeting | 23 y 24 de mayo de 2025 | Hospital Clínico San Carlos, Madrid